Skip to content

Beneficial Efficacy of Carperitide in Patients with Acute Decompensated Heart Failure

Beneficial Efficacy of Carperitide in Patients with Acute Decompensated Heart Failure - BEYOND registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028689
Enrollment
200
Registered
2018-08-29
Start date
2017-07-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure (ADHF)

Interventions

None listed

Sponsors

Tokai University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Acute decompensated heart failure (ADHF) daignosed according to guidelines of American College of Cardiology (ACC)/ American Heart Association (AHA). 2. Patients who are administered carperitide within 6 hours after diagnosis of ADHF. 3. Over 20 years old. 4. Patients who gave consent with registration in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with circulatory assist device 2. Severe hypotension or cardiogenic shock 3. Patients with dehydration 4. Patients with hemodialysis 5. Allergy with carperitide 6. Pregnant women, lactational women, patients may be pregnant or will be pregnant 7. Patitents with acute coronary syndrome 8. Patients who were judged as inappropriate to be enrolled by physician

Design outcomes

Primary

MeasureTime frame
Total urine volume at 6 hours after an administration of carperitide.

Secondary

MeasureTime frame
1.Total urine volume at 12, 24, and 48 hours after an administration of carperitide. 2.Acute kidney injury. 3.Serum Hb, Ht, Cr, BUN, Na, K, Cl, BNP, ANP levels. 4.Urinary findings. 5.Usage and dosage of other diuretic drugs. 6.Symptoms. 7.Congestive physical findings. 8.Duration of hospitalization. 9.Adverse events in hospitalization.

Countries

Japan

Contacts

Public ContactMatsumoto Matsumoto

Toho University Faculty of Medicine Department of Cardiology

shingomatsumoto0606@gmail.com0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026